Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC MedChemExpress Daraxonrasib, RAS (ON) Inhibitor, Orally Active, Non-Covalent
Supplier: Medchemexpress LLC HY1484392X400MG
Daraxonrasib (RMC-6236) is an orally active, non-covalent RAS (ON) inhibitor. It disrupts the interaction of wild-type or mutant RAS proteins with the RAS binding domain of BRAF, inhibits pERK, and exhibits anti-tumor activity against KRAS mutant tumors.
- Orally active, non-covalent RAS (ON) inhibitor.
- Disrupts interaction of wild-type or mutant RAS proteins with BRAF’s RAS binding domain.
- Inhibits pERK.
- Has anti-tumor activity against KRAS mutant tumors.
- Potently inhibits the growth of KRAS mutant cancer cell lines HPAC and Capan-2.
- Shows dose-dependent antitumor activity in various human tumor xenograft models harboring prevalent KRAS mutations.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?